Albemarle Corporation
$79.70-$3.23 (-3.9%)
Last close · Data as of Nov 20, 2026
- Market cap
- $19.5B
- EV / EBITDA
- 67.5x
- Revenue
- $5.1B
- Net margin
- -13.2%
- ROCE
- -3.3%
Price chart
Technical chartScreen technicals →-31.5% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -16.8%
- 3M
- -40.6%
- 6M
- -53.2%
- 1Y
- -31.5%
- 5Y
- -71.7%
52-week range
Day change -$3.23 (-3.9%) from $83 to $80 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in ALB, bought on each weekday since 2021.
News & filings
What Albemarle filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe company made a net loss of 511 million US dollars in fiscal 2025.
Strengths (1)
- Current assets are 2.23 times current liabilities.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen.
Read moreShow less
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles, power grids and solar panels, high performance greases, specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemicals products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates in the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
- Sector
- Basic Materials
- Shares outstanding
- 117.7M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $19.5B
- P/B
- 2.0x
- EV / EBITDA
- 67.5x
- EV / Sales
- 4.1x
- P/S
- 3.8x
- 52-week high
- $215.62
- 52-week low
- $79.70
Profitability
- Operating margin
- 1.3%
- Net margin
- -13.2%
- EBITDA margin
- 6.1%
- ROE
- -7.1%
- ROCE
- -3.3%
- ROA
- -4.1%
- Asset turnover
- 0.31
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $5.1B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -4.4%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- -11.1%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -56.7%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $692.5M
Solvency
- Current ratio
- 2.23
- Debt / Equity
- 0.35
- Debt / Assets
- 0.20
- CFO / Net profit
- -1.89
- Cash / Market cap
- 8.3%
Where the revenue went
FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.
| Line | FY2025 |
|---|---|
| Revenue | $5.1B |
| Cost of revenue | $4.5B |
| Gross profit | $668.7M |
| Operating expenses | $601.4M |
| Research and development | $51.4M |
| Selling, general and administrative | $550.0M |
| Operating income | $67.3M |
| Interest and other | -$619.4M |
| Pretax income | -$552.1M |
| Tax and other | -$41.4M |
| Net income | -$510.6M |
Revenue and net profit
Revenue fell 4.4% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $7.3B | $2.7B |
| FY2023 | $9.6B | $1.6B |
| FY2024 | $5.4B | -$1.2B |
| FY2025 | $5.1B | -$510.6M |
Cash flows
FY2025: $1.3B from operations, $692.5M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $1.9B | $646.2M |
| FY2023 | $1.3B | -$828.0M |
| FY2024 | $687.9M | -$992.7M |
| FY2025 | $1.3B | $692.5M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $5.1B-4.4%1Y
- EBITDA
- $314.3M
- Net profit
- -$510.6M
- Cash from operations
- $1.3B+86.4%1Y
- Free cash flow
- $692.5M
- Revenue CAGR, 3Y
- -11.1%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $5.1B | $314.3M | -$510.6M | $692.5M | -7.0% | -4.4% | -56.7% |
Monthly returns
Month-by-month returns of ALB across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $16.4B |
| Current assets | $4.0B |
| Non-current assets | $12.4B |
| Liabilities | $6.6B |
| Current liabilities | $1.8B |
| Non-current liabilities | $4.8B |
| Equity | $9.8B |
| Paid-in capital | $3.0B |
| Retained earnings | $4.6B |
| Minority interest | $248.1M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Basic Materials companies placed by value, growth and quality; ALB highlighted.
P/E against peers
Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Albemarle CorporationALBthis company | $19.5B | — | 2.0x | -7.1% | 67.5x |
| Vulcan Materials CompanyVMC | $36.7B | 34.1x | 4.3x | 12.6% | 17.6x |
| Martin Marietta Materials, Inc.MLM | $34.9B | 30.7x | 3.5x | 11.3% | 19.4x |
| Dow Inc.DOW | $25.1B | -9.6x | 1.6x | -16.4% | 34.4x |
| PPG Industries, Inc.PPG | $25.0B | 15.8x | 3.1x | 19.8% | 10.9x |
| LyondellBasell Industries N.V.LYB | $21.4B | — | 2.1x | -7.5% | 28.0x |
| DuPont de Nemours, Inc.DD | $19.3B | -24.8x | 1.4x | -5.6% | 18.8x |
| International Flavors & Fragrances Inc.IFF | $18.7B | — | 1.3x | -2.6% | 31.7x |
| CF Industries Holdings, Inc.CF | $18.1B | 12.4x | 3.7x | 30.1% | 6.0x |
| Peer median | — | 14.1x | 2.6x | 4.4% | 19.1x |
Year-to-date ROI
ALB since 1 January, against earlier years.
Historical volatility
ALB's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 33.9% |
| FY2023 | 2.0% |
| FY2024 | -11.9% |
| FY2025 | 1.3% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $5.1B |
| Cost of revenueCost Of Revenue | $4.5B |
| Gross profitGross Profit | $668.7M |
| Operating expensesOperating Expense | $601.4M |
| Research and developmentResearch And Development | $51.4M |
| Selling, general and administrativeSelling General And Administration | $550.0M |
| Total expensesTotal Expenses | $5.1B |
| Operating incomeOperating Income | $67.3M |
| Interest and other | |
| Pretax incomePretax Income | -$552.1M |
| TaxTax Provision | $156.9M |
| Net incomeNet Income | -$510.6M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $16.4B |
| Current assetsCurrent Assets | $4.0B |
| Non-current assetsTotal Non Current Assets | $12.4B |
| LiabilitiesTotal Liabilities Net Minority Interest | $6.6B |
| Current liabilitiesCurrent Liabilities | $1.8B |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $4.8B |
| EquityTotal Equity Gross Minority Interest | $9.8B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $1.3B |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $1.3B |
| Net income, continuing operationsNet Income From Continuing Operations | -$465.2M |
| Depreciation and amortisationDepreciation And Amortization | $658.7M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $658.7M |
| Stock-based compensationStock Based Compensation | $40.3M |
| Deferred taxDeferred Tax | $81.2M |
| Deferred income taxDeferred Income Tax | $81.2M |
| Operating gains and lossesOperating Gains Losses | -$233.3M |
| Gain loss on investment securitiesGain Loss On Investment Securities | — |
| Gain loss on sale of PP&EGain Loss On Sale Of PPE | — |
| Gain loss on sale of businessGain Loss On Sale Of Business | $0.00 |
| Unrealized gain loss on investment securitiesUnrealized Gain Loss On Investment Securities | -$14.1M |
| Earnings losses from equity investmentsEarnings Losses From Equity Investments | -$243.7M |
| Asset impairmentAsset Impairment Charge | $426.7M |
| Pension and employee benefit expensePension And Employee Benefit Expense | $2.9M |
| Change in working capitalChange In Working Capital | $694.4M |
| Other non-cash itemsOther Non Cash Items | — |
| Dividend received (operating)Dividend Received Cfo | $93.7M |
| Investing cash flowInvesting Cash Flow | -$146.0M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$146.0M |
| Capital expenditureCapital Expenditure | -$589.8M |
| Capital expenditure (reported)Capital Expenditure Reported | -$589.8M |
| Sale of PP&ESale Of PPE | $32.8M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | $32.8M |
| AcquisitionsPurchase Of Business | -$240.0k |
| DisposalsSale Of Business | — |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$240.0k |
| Purchase of investmentsPurchase Of Investment | — |
| Sale of investmentsSale Of Investment | $411.2M |
| Net investment purchases and salesNet Investment Purchase And Sale | $411.2M |
| Financing cash flowFinancing Cash Flow | -$834.2M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$834.2M |
| Debt issuedIssuance Of Debt | $56.7M |
| Debt repaidRepayment Of Debt | -$511.4M |
| Net debt issuedNet Issuance Payments Of Debt | -$454.7M |
| Long-term debt issuedLong Term Debt Issuance | $56.7M |
| Long-term debt repaidLong Term Debt Payments | -$511.4M |
| Net long-term debt issuedNet Long Term Debt Issuance | -$454.7M |
| Shares issuedIssuance Of Capital Stock | $0.00 |
| Common stock issuedCommon Stock Issuance | — |
| Net common stock issuedNet Common Stock Issuance | — |
| Stock options exercisedProceeds From Stock Option Exercised | $3.2M |
| Preferred stock issuancePreferred Stock Issuance | $0.00 |
| Net preferred stock issuanceNet Preferred Stock Issuance | $0.00 |
| Dividends paidCash Dividends Paid | -$357.3M |
| Common dividends paidCommon Stock Dividend Paid | -$190.5M |
| Preferred stock dividend paidPreferred Stock Dividend Paid | -$166.8M |
| Other financing chargesNet Other Financing Charges | -$25.5M |
| Change in cashChanges In Cash | $302.1M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | 12,370.0% |
| Cash at the start of the yearBeginning Cash Position | $1.2B |
| Cash at the end of the yearEnd Cash Position | $1.6B |
| Free cash flowFree Cash Flow | $692.5M |
| Supplemental |
Learn while you research
Academy chapters picked for Albemarle Corporation and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read